Serum NT-proBNP levels can reflect the cardiovascular status of patients with early-stage severe HFMD and may help clinicians to identify patients with worse prognosis before they develop pulmonary oedema, pulmonary haemorrhage, or heart failure. This evidence concerns the gene NPPB and heart failure.